Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hepatitis C virus in sub-Saharan Africa: a long road to elimination.
Shah R, Agyei-Nkansah A, Alikah F, Asamoah-Akuoko L, Bagou YCO, Dhiblawe A, Ehichioya D, Finch PJ, Katsidzira L, Kodjoh N, Kpossou RA, Lakoh S, Makuza JD, Marowa L, Ndububa DA, Mbendi CN, Nyirenda M, Ocama P, Opio CK, Seremba E, Shindano TA, Thomson EC; Hepatitis C Virus sub-Saharan Africa Network. Shah R, et al. Among authors: makuza jd. Lancet Gastroenterol Hepatol. 2021 Sep;6(9):693-694. doi: 10.1016/S2468-1253(21)00224-7. Lancet Gastroenterol Hepatol. 2021. PMID: 34391525 Free article. No abstract available.
Safety and efficacy of sofosbuvir-velpatasvir-voxilaprevir for re-treatment of chronic hepatitis C virus infection in patients with previous direct-acting antiviral treatment failure in Rwanda (SHARED-3): a single-arm trial.
Gupta N, Manirambona L, Shumbusho F, Kabihizi J, Murangwa A, Serumondo J, Makuza JD, Nsanzimana S, Muvunyi CM, Mukabatsinda C, Musabeyezu E, Camus G, Grant PM, Kateera F. Gupta N, et al. Among authors: makuza jd. Lancet Gastroenterol Hepatol. 2022 Jun;7(6):542-551. doi: 10.1016/S2468-1253(21)00399-X. Epub 2022 Mar 3. Lancet Gastroenterol Hepatol. 2022. PMID: 35248212 Clinical Trial.
Safety and efficacy of sofosbuvir-velpatasvir to treat chronic hepatitis C virus infection in treatment-naive patients in Rwanda (SHARED-3): a single-arm trial.
Kateera F, Shumbusho F, Manirambona L, Kabihizi J, Murangwa A, Serumondo J, Makuza JD, Nsanzimana S, Muvunyi CM, Kabakambira JD, Sylvain H, Camus G, Grant PM, Gupta N. Kateera F, et al. Among authors: makuza jd. Lancet Gastroenterol Hepatol. 2022 Jun;7(6):533-541. doi: 10.1016/S2468-1253(21)00398-8. Epub 2022 Mar 3. Lancet Gastroenterol Hepatol. 2022. PMID: 35248213 Clinical Trial.
Implementation of a unique hepatitis C care continuum model in Rwanda.
Mathur P, Comstock E, Makuza JD, Emmanuel B, Sebeza J, Kiromera A, Wilson E, Kattakuzhy S, Nelson A, Kottilil S, Riedel DJ. Mathur P, et al. Among authors: makuza jd. J Public Health (Oxf). 2019 Jun 1;41(2):e203-e208. doi: 10.1093/pubmed/fdy115. J Public Health (Oxf). 2019. PMID: 29982813
Improved quality of life following direct-acting antiviral treatment for chronic hepatitis C infection in Rwanda: Results from a clinical trial in sub-Saharan Africa (the SHARED study).
Van Nuil JI, Umutesi G, Shumbusho F, Kateera F, Dushimimana JD, Muvunyi CM, Musabeyezu E, Mukabatsinda C, Ntirenganya C, Kabahizi J, Serumondo J, Makuza JD, Nsanzimana S, Grant P, Gupta N. Van Nuil JI, et al. Among authors: makuza jd. J Viral Hepat. 2021 Jan;28(1):112-120. doi: 10.1111/jvh.13386. Epub 2020 Oct 4. J Viral Hepat. 2021. PMID: 32858774
Initiation of hepatitis C treatment in two rural Rwandan districts: a mobile clinic approach.
Kamali I, Barnhart DA, Nyirahabihirwe F, de la Paix Gakuru J, Uwase M, Nizeyumuremyi E, Walker S, Mazimpaka C, de Dieu Gatete J, Makuza JD, Serumondo J, Kateera F, d'Amour Ndahimana J. Kamali I, et al. Among authors: makuza jd. BMC Infect Dis. 2021 Feb 25;21(1):220. doi: 10.1186/s12879-021-05920-3. BMC Infect Dis. 2021. PMID: 33632165 Free PMC article.
Knowledge among patients with Hepatitis C initiating on direct-acting antiviral treatment in rural Rwanda: A prospective cohort study.
Barnhart DA, Kamali I, Nyirahabihirwe F, Mugabo C, Gakuru JP, Uwase M, Nizeyumuremyi E, Musafiri T, Gatete JD, Makuza JD, Kateera F, Hedt-Gauthier B, Ndahimana JD. Barnhart DA, et al. Among authors: makuza jd. Glob Health Action. 2021 Jan 1;14(1):1953250. doi: 10.1080/16549716.2021.1953250. Glob Health Action. 2021. PMID: 34347569 Free PMC article.
Time to complete hepatitis C cascade of care among patients identified during mass screening campaigns in rural Rwanda: a retrospective cohort study.
Kamali I, Shumbusho F, Barnhart DA, Nyirahabihirwe F, Gakuru JP, Dusingizimana W, Nizeyumuremyi E, Habinshuti P, Walker S, Makuza JD, Serumondo J, Nshogoza Rwibasira G, Ndahimana JD. Kamali I, et al. Among authors: makuza jd. BMC Infect Dis. 2022 Mar 21;22(1):272. doi: 10.1186/s12879-022-07271-z. BMC Infect Dis. 2022. PMID: 35313817 Free PMC article.
Impact of Hepatitis B Virus Infection, Non-alcoholic Fatty Liver Disease, and Hepatitis C Virus Co-infection on Liver-Related Death among People Tested for Hepatitis B Virus in British Columbia: Results from a Large Longitudinal Population-Based Cohort Study.
Makuza JD, Jeong D, Binka M, Adu PA, Cua G, Yu A, Velásquez García HA, Alvarez M, Wong S, Bartlett S, Karim ME, Yoshida EM, Ramji A, Krajden M, Janjua NZ. Makuza JD, et al. Viruses. 2022 Nov 21;14(11):2579. doi: 10.3390/v14112579. Viruses. 2022. PMID: 36423186 Free PMC article.
36 results